SG11201805204WA - Nicotine particle capsule - Google Patents

Nicotine particle capsule

Info

Publication number
SG11201805204WA
SG11201805204WA SG11201805204WA SG11201805204WA SG11201805204WA SG 11201805204W A SG11201805204W A SG 11201805204WA SG 11201805204W A SG11201805204W A SG 11201805204WA SG 11201805204W A SG11201805204W A SG 11201805204WA SG 11201805204W A SG11201805204W A SG 11201805204WA
Authority
SG
Singapore
Prior art keywords
international
pct
capsule
english
december
Prior art date
Application number
SG11201805204WA
Inventor
Gerard Zuber
Nicolo Volpe
Original Assignee
Philip Morris Products Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Philip Morris Products Sa filed Critical Philip Morris Products Sa
Publication of SG11201805204WA publication Critical patent/SG11201805204WA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/24—Treatment of tobacco products or tobacco substitutes by extraction; Tobacco extracts
    • A24B15/241—Extraction of specific substances
    • A24B15/243—Nicotine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/186—Treatment of tobacco products or tobacco substitutes by coating with a coating composition, encapsulation of tobacco particles
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
    • A24F15/00—Receptacles or boxes specially adapted for cigars, cigarettes, simulated smoking devices or cigarettes therefor
    • A24F15/01—Receptacles or boxes specially adapted for cigars, cigarettes, simulated smoking devices or cigarettes therefor specially adapted for simulated smoking devices or cigarettes therefor
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
    • A24F42/00—Simulated smoking devices other than electrically operated; Component parts thereof; Manufacture or testing thereof
    • A24F42/20—Devices without heating means
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
    • A24F42/00—Simulated smoking devices other than electrically operated; Component parts thereof; Manufacture or testing thereof
    • A24F42/60—Constructional details
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0001—Details of inhalators; Constructional features thereof
    • A61M15/0021—Mouthpieces therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/003—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/003—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
    • A61M15/0033—Details of the piercing or cutting means
    • A61M15/0035—Piercing means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/06—Inhaling appliances shaped like cigars, cigarettes or pipes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/06—Solids
    • A61M2202/064—Powder

Abstract

INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property -, Organization IIIM1411011101010111110101111 1011101011011101100111 10111110H III International Bureau .. .... ..Yejd (10) International Publication Number (43) International Publication Date ..... .....1 WO 2017/109678 Al 29 June 2017(29.06.2017) WIPO I PCT (51) International Patent Classification: AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, A61M 15/00 (2006.01) A61K 31/465 (2006.01) BZ, A61111 15/06 (2006.01) DO, HN, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, (21) International Application Number: KP, PCT/IB2016/057792 MD, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, (22) International Filing Date: NI, 19 December 2016 (19.12.2016) RU, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, (25) Filing Language: English ZA, ZM, ZW. (26) Publication Language: English (84) Designated States (unless otherwise indicated, for every (30) Priority Data: kind 15202712.4 24 December 2015 (24.12.2015) EP GM, of regional protection available): ARIPO (BW, GH, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, 16201580.4 30 November 2016 (30.11.2016) EP TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, (71) Applicant: PHILIP MORRIS PRODUCTS S.A. DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, [CH/CH]; Quai Jeanrenaud 3, 2000 Neuchatel (CH). LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, (72) Inventors: ZUBER, Gerard; Route du Chalet a Gobet 2, SM, GW, KM, ML, MR, NE, SN, TD, TG). 1055 Froideville (CH). VOLPE, Nicolo; Chemin des Di- TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, ablerets 16, 1012 Lausanne (CH). Published: (81) Designated States (unless otherwise indicated, for every — with kind of national protection available): AE, AG, AL, AM, international search report (Art. 21(3)) (54) Title: NICOTINE PARTICLE CAPSULE 112 *1 0000 i 0000 00 114 113 4 GC IN v:; cr, © ,—, IN 120 Fig. 1 1-1 (57) : A capsule containing particles including nicotine wherein a single aperture extends through the capsule. 0 ei O
SG11201805204WA 2015-12-24 2016-12-19 Nicotine particle capsule SG11201805204WA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP15202712 2015-12-24
EP16201580 2016-11-30
PCT/IB2016/057792 WO2017109678A1 (en) 2015-12-24 2016-12-19 Nicotine particle capsule

Publications (1)

Publication Number Publication Date
SG11201805204WA true SG11201805204WA (en) 2018-07-30

Family

ID=57822002

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201805204WA SG11201805204WA (en) 2015-12-24 2016-12-19 Nicotine particle capsule

Country Status (18)

Country Link
US (1) US10960152B2 (en)
EP (1) EP3393565B1 (en)
JP (1) JP7242300B2 (en)
KR (1) KR20180096611A (en)
CN (1) CN108430551A (en)
AU (1) AU2016376033A1 (en)
BR (1) BR112018010830B1 (en)
CA (1) CA3008996A1 (en)
ES (1) ES2948157T3 (en)
IL (1) IL259910A (en)
MX (1) MX2018007512A (en)
PH (1) PH12018501199A1 (en)
PL (1) PL3393565T3 (en)
RU (1) RU2720573C2 (en)
SG (1) SG11201805204WA (en)
UA (1) UA123586C2 (en)
WO (1) WO2017109678A1 (en)
ZA (1) ZA201803662B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7069197B2 (en) 2017-02-28 2022-05-17 フィリップ・モーリス・プロダクツ・ソシエテ・アノニム Aerosol generator with powder deagglomerating actuator
BR112019025635A2 (en) * 2017-06-28 2020-06-23 Philip Morris Products S.A. PARTICLE CONTAINER FOR USE WITH INHALER
KR20200077514A (en) * 2017-10-25 2020-06-30 필립모리스 프로덕츠 에스.에이. Inhaler with boundary elements
CN114642275A (en) * 2017-10-25 2022-06-21 菲利普莫里斯生产公司 Piercing attachment for inhaler articles and systems
US11744960B2 (en) 2017-12-28 2023-09-05 Philip Morris Products S.A. Inhaler with vortex tunnel
CN111526747B (en) * 2018-02-19 2023-11-07 菲利普莫里斯生产公司 dry powder inhaler
JP7458985B2 (en) 2018-03-26 2024-04-01 フィリップ・モーリス・プロダクツ・ソシエテ・アノニム Inhaler with composite porous support element
BR112020016528A2 (en) * 2018-03-26 2020-12-15 Philip Morris Products S.A. INHALER WITH POROUS SUPPORT ELEMENT WITH OPENING
BR112020016652A2 (en) 2018-03-26 2020-12-15 Philip Morris Products S.A. INHALER WITH VORTEX CAPSULE CAVITY

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4069819A (en) 1973-04-13 1978-01-24 Societa Farmaceutici S.P.A. Inhalation device
GB1521000A (en) * 1975-06-13 1978-08-09 Syntex Puerto Rico Inc Inhalation device
US4695274A (en) 1986-01-31 1987-09-22 Fox Richard L Protected hypodermic needle
US4790305A (en) 1986-06-23 1988-12-13 The Johns Hopkins University Medication delivery system
US4735217A (en) 1986-08-21 1988-04-05 The Procter & Gamble Company Dosing device to provide vaporized medicament to the lungs as a fine aerosol
GB8804069D0 (en) 1988-02-22 1988-03-23 Britains Petite Ltd Dispensers for powdered medication
IT1228459B (en) 1989-02-23 1991-06-19 Phidea S R L INHALER WITH REGULAR AND COMPLETE EMPTYING OF THE CAPSULE.
NO168921C (en) 1989-07-31 1992-04-22 Svein Knudsen SMOKE-FREE Cigarette replacement for use in smoking cessation OR FOR USE IN SMOKE-FREE ENVIRONMENTS
US5441060A (en) 1993-02-08 1995-08-15 Duke University Dry powder delivery system
PT101450B (en) * 1994-02-02 1999-11-30 Hovione Produtos Farmaceuticos NEW INHALATION DEVICE
US6102036A (en) 1994-04-12 2000-08-15 Smoke-Stop Breath activated inhaler
US6234169B1 (en) * 1998-08-14 2001-05-22 Arthur Slutsky Inhaler
GB0009468D0 (en) * 2000-04-17 2000-06-07 Vectura Ltd Improvements in or relating to formulations for use in inhaler devices
PE20011227A1 (en) 2000-04-17 2002-01-07 Chiesi Farma Spa PHARMACEUTICAL FORMULATIONS FOR DRY POWDER INHALERS IN THE FORM OF HARD AGGLOMERATES
US6681768B2 (en) 2001-06-22 2004-01-27 Sofotec Gmbh & Co. Kg Powder formulation disintegrating system and method for dry powder inhalers
US20040206350A1 (en) 2002-12-19 2004-10-21 Nektar Therapeutics Aerosolization apparatus with non-circular aerosolization chamber
US20050081852A1 (en) * 2002-12-30 2005-04-21 Nektar Therapeutics (Formely Inhale Therapeutic System Inc.) Package for an aerosolization apparatus and pharmaceutical formulation receptacle
US7669596B2 (en) * 2002-12-31 2010-03-02 Novartis Pharma Ag Aerosolization apparatus with rotating capsule
CA2511523C (en) * 2002-12-31 2013-10-15 Nektar Therapeutics Pharmaceutical formulation with an insoluble active agent for pulmonary administration
US20050056280A1 (en) * 2002-12-31 2005-03-17 Nektar Therapeutics Receptacle for an aerosolizable pharmaceutical formulation
DE602004014909D1 (en) * 2003-03-20 2008-08-21 Galephar M F IMPROVED DRY POWDER INHALATION SYSTEM
WO2004112702A2 (en) * 2003-06-13 2004-12-29 Advanced Inhalation Research, Inc. Low dose pharmaceutical powders for inhalation
GB2415597A (en) * 2004-07-01 2006-01-04 Christopher Owen Hackling Cigarette
ATE443658T1 (en) 2005-11-21 2009-10-15 Mannkind Corp POWDER DISPENSING AND COLLECTION APPARATUS AND METHOD
GB2461008B (en) 2006-12-08 2011-08-10 Exchange Supplies Ltd Nicotine inhalation device
US10668058B2 (en) 2007-03-30 2020-06-02 Philip Morris Products S.A. Device and method for delivery of a medicament
AU2008335821B2 (en) 2007-12-05 2012-12-20 Novartis Ag Receptacle for an aerosolizable pharmaceutical formulation
US8485180B2 (en) * 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
AT507631B1 (en) * 2008-11-26 2012-05-15 Haas Rouven Mag DEVICE FOR INTAKING POWDER OR GRANULATE MATERIAL AND CAPSULE THEREFOR
CN102395398B (en) 2009-02-23 2016-03-16 日本烟草产业株式会社 Non-power pattern of fever tobacco flavor extractor
US8813759B1 (en) 2010-11-18 2014-08-26 Richard C. Horian Nicotine inhaler and method of manufacture
US8561609B2 (en) 2010-12-07 2013-10-22 Respira Therapeutics, Inc. Dry powder inhaler
JP6037315B2 (en) 2011-05-27 2016-12-07 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Inhaler and capsule for inhaler
EP2731572B1 (en) 2011-07-13 2021-04-07 Pharmaxis Ltd. Improvements relating to delivery devices
US20140088045A1 (en) 2012-09-21 2014-03-27 Basil Rigas Product comprising a nicotine-containing material and an anti-cancer agent
EP3136894B1 (en) * 2014-04-28 2019-07-31 Philip Morris Products S.A. Nicotine powder inhaler
AU2015254999B2 (en) 2014-04-28 2019-08-01 Philip Morris Products S.A. Flavoured nicotine powder inhaler
JP6718383B2 (en) * 2014-06-20 2020-07-08 フィリップ・モーリス・プロダクツ・ソシエテ・アノニム Nicotine powder delivery system with control means
PL3160271T3 (en) * 2014-06-27 2020-05-18 Philip Morris Products S.A. Aerosol-generating system with improved piercing member
US11033692B2 (en) * 2015-04-15 2021-06-15 Philip Morris Products S.A. Flavoring element for an inhalation device
US20170071248A1 (en) * 2015-09-16 2017-03-16 Sansa Corporation (Barbados) Inc. System and Method for Controlling the Harshness of Nicotine-Based Dry Powder Formulations

Also Published As

Publication number Publication date
EP3393565A1 (en) 2018-10-31
WO2017109678A1 (en) 2017-06-29
CA3008996A1 (en) 2017-06-29
MX2018007512A (en) 2018-09-17
RU2018126867A3 (en) 2020-03-17
PL3393565T3 (en) 2023-09-11
IL259910A (en) 2018-07-31
JP2019508015A (en) 2019-03-28
RU2720573C2 (en) 2020-05-12
CN108430551A (en) 2018-08-21
KR20180096611A (en) 2018-08-29
JP7242300B2 (en) 2023-03-20
RU2018126867A (en) 2020-01-24
BR112018010830A2 (en) 2018-11-27
UA123586C2 (en) 2021-04-28
EP3393565B1 (en) 2023-05-24
ZA201803662B (en) 2019-07-31
AU2016376033A1 (en) 2018-06-28
BR112018010830B1 (en) 2023-04-11
ES2948157T3 (en) 2023-09-01
US20190001084A1 (en) 2019-01-03
US10960152B2 (en) 2021-03-30
PH12018501199A1 (en) 2019-01-28

Similar Documents

Publication Publication Date Title
SG11201805204WA (en) Nicotine particle capsule
SG11201805072PA (en) Nicotine powder delivery system
SG11201809040YA (en) Hybrid aerosol-generating element and method for manufacturing a hybrid aerosol-generating element
SG11201811250TA (en) Nicotine inhaler system
SG11201909949XA (en) Targeted immunotolerance
SG11201807401RA (en) Therapeutic membrane vesicles
SG11201804758QA (en) Aqueous pharmaceutical formulation comprising anti-pd-1 antibody avelumab
SG11201809594WA (en) Nicotine particles and compositions
SG11201808990QA (en) Compositions for topical application of compounds
SG11201808125RA (en) Methods for solid tumor treatment
SG11201807252QA (en) Anti-lag-3 antibodies
SG11201809617RA (en) Intracellular delivery of biomolecules to induce tolerance
SG11201404854RA (en) Aerosol-generating article having a flavour-generating component
SG11201805950UA (en) Self-assembled nanostructures and separation membranes comprising aquaporin water channels and methods of making and using them
SG11201809630RA (en) Nicotine particles
SG11201809499UA (en) Processes for preparing phosphorodiamidate morpholino oligomers
SG11201408251SA (en) A pharmaceutical composition containing nicotinic acid and/or nicotinamide and/or tryptophan for positively influencing the intestinal microbiota
SG11201809908TA (en) Stabilized glycopeptide antibiotic formulations
SG11201810965YA (en) 1h-pyrazolo[4,3-b]pyridines as pde1 inhibitors
SG11201808525UA (en) Anti-complement factor bb antibodies and uses thereof
SG11201901438VA (en) Solid forms of cenicriviroc mesylate and processes of making solid forms of cenicriviroc mesylate
SG11201805001UA (en) Method of treating influenza a
SG11201811746TA (en) Nicotine particle delivery consumable
SG11201804094UA (en) Pack for preparing food or beverage products
SG11201804712PA (en) Biofuel